Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
IMNN

Imunon, Inc. (IMNN)

NASDAQ
$0.58
-$0.04
(-6.22%)
Previous Close: ⁦$0.61⁩
Market Closed

Last updated: ⁦2026-11-19 04:24:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Imunon, Inc. (IMNN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.58, with a market capitalization of $3.85M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.50 to $4.35. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$3.85M

$0.64

$0.68

$0.58

$0.61

74.61K

153.69K

--

$4.35

$0.50

--

2026-06-30

Imunon, Inc. (IMNN) Latest Closing Stock Price

Imunon, Inc. (IMNN) last closed at $0.58 as of 2026-11-19 00:49:00, down 6.22% ($0.04) from the previous close of $0.61.

During the latest regular trading session, IMNN traded between $0.58 and $0.68, with a volume of 74.61K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Imunon, Inc. (IMNN) 7-Day Stock Price Change

Over the past seven days, Imunon, Inc. (IMNN) moved from $0.88 to $0.58, representing a decline of 33.85% ($0.30).

The stock traded between $0.50 and $0.95 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 437.60 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

IMNN 52-Week Price Position

Position in Range: 2.3%

52W Low$0.50
52W High$4.35

IMNN is currently trading at $0.58, placing it 2.3% of the way from its 52-week low of $0.50 to its 52-week high of $4.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Imunon, Inc. (IMNN)?

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Imunon, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
20
Exchange
NASDAQ
Company Website

IMNN News

Latest news related to Imunon, Inc. and IMNN stock.

  • Benzinga

    Imunon Q3 2026 Earnings Call Transcript

    Imunon (NASDAQ:IMNN) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For

    Read Full Article
  • Benzinga

    Imunon Q3 EPS $(0.64) Misses $(0.55) Estimate

    Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.55) by 16.36 percent. This is a 44.83 percent increase over losses of $(1.16) per share from the

    Read Full Article
  • Massive

    IMUNON Reports Third Quarter 2026 Financial Results and Provides Business Update

    IMUNON reported Q3 2026 financial results with a net loss of $3.8 million. The company highlighted progress in its Phase 3 OVATION 3 trial of IMNN-001, a DNA-based immunotherapy for advanced ovarian cancer, with enrollment expected to complete by Q1 2029. Recent developments include a collaboration with the National Cancer Institute, positive Phase 2 data showing overall survival benefits, and strategic moves to strengthen financial position including transitioning ThermoDox to VoxelDox and completing a debt-for-equity exchange.

    Read Full Article

Ways to Trade IMNN at MEXC

IMNN MEXC RealStocks

Own real IMNN shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Imunon, Inc. (IMNN) Stock on MEXC

Eligible investors can buy real shares of Imunon, Inc. (IMNN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for IMNN and Place Your Order
Step 3: Search for IMNN and Place Your Order
Open the RealStocks trading page and search for IMNN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Imunon, Inc. (IMNN) stock price today?
Imunon, Inc. (IMNN) is currently trading at $0.58, down 6.22% ($0.04) from the previous close of $0.61. Intraday prices update in real time during regular trading hours.
2.Is IMNN stock going up or down today?
As of 2026-11-19 00:49:00, IMNN is trading at $0.58, down 6.22% ($0.04) from its previous close of $0.61. The stock has traded between $0.58 and $0.68 during today’s regular session. Past price movements do not guarantee future results.
3.What is IMNN pre-market price?
As of 2026-11-19 00:49:00, IMNN is trading at $0.64 in pre-market trading, up 4.54% ($0.03) from the previous close of $0.61. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is IMNN after-hours price?
As of 2026-11-19 00:49:00, IMNN is trading at $0.67 in after-hours trading, up 15.24% ($0.09) from the regular-session close of $0.58. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is IMNN stock trading now?
IMNN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does IMNN sit relative to its 52-week high and low?
Over the past 52 weeks, IMNN has traded between a low of $0.50 and a high of $4.35. At $0.58, the stock is positioned 2.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Imunon, Inc. in?
Imunon, Inc. (IMNN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Imunon, Inc.'s market capitalization and where is it listed?
Imunon, Inc. is listed on the NASDAQ exchange with a market capitalization of $3.85M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is IMNN valued in terms of P/E ratio and EPS?
IMNN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-2.32. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Imunon, Inc. pay a dividend?
Imunon, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IMNN, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

IMNN Stock Calculator

Estimate the value between IMNN shares and USD.

IMNN Shares to USD

IMNN Shares
IMNN
IMNN
USD
USD
USD

1.00 IMNN shares = 0.584 USD

Calculations are estimates based on the latest available price and are for reference only.